Infections Clinical Trial
Official title:
Clozapine-associated Infection
NCT number | NCT05919550 |
Other study ID # | Clozinfection |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 11, 2023 |
Est. completion date | April 11, 2023 |
Verified date | April 2023 |
Source | University Hospital, Caen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
perform a study in VigiBase® to assess if clozapine was associated with an over-reporting of infections and to characterize those infections. The investigators also decided to assess the dose dependency associated with those infections.
Status | Completed |
Enrollment | 26815616 |
Est. completion date | April 11, 2023 |
Est. primary completion date | April 11, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Case reported in the World Health Organization (WHO) database of individual safety case reports to 11/04/2023 - Adverse events reported were including the MedDRA terms: infections (SOC) Exclusion Criteria: Chronology not compatible between the drug and the toxicity |
Country | Name | City | State |
---|---|---|---|
France | Caen University Hospital, Department of Pharmacology | Caen | Normandie |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correlation between clozapine and hinfections using a disproportionality analysis in Individual Case Reports involving at least one liable antipsychotic drug in Vigibase® | from the 01/01/1963 to the 11/04/2023 | ||
Secondary | investigate a potential dose-dependent effect | A logistical regression model will be applied to search for a dose-dependant effect of infection using clozapine quartile doses. | from the 01/01/1963 to the 11/04/2023 | |
Secondary | Description of the clinical features of clozapine-related infections | Description of age, sex, time to onset, type of infections using MedDRA | from the 01/01/1963 to the 11/04/2023 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06055777 -
Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts
|
Phase 1 | |
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Recruiting |
NCT05793983 -
S100A8/A9 and Innate Immunity in Liver Disease
|
||
Active, not recruiting |
NCT05963269 -
The Effect of the Game on Students' Intramuscular Injection Skills
|
N/A | |
Not yet recruiting |
NCT06026852 -
Validation of Betalactam ML Prediction Models - TDMAide
|
N/A | |
Not yet recruiting |
NCT02222779 -
Quantification of Transition Metals
|
N/A | |
Completed |
NCT01976234 -
Stored RBC Transfusion and Immonomodulation
|
N/A | |
Completed |
NCT02345135 -
Susceptibility to Infections in Ataxia Telangiectasia
|
N/A | |
Completed |
NCT01530763 -
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
|
Phase 2/Phase 3 | |
Completed |
NCT01158560 -
A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections
|
Phase 3 | |
Completed |
NCT01176786 -
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
|
N/A | |
Active, not recruiting |
NCT05284097 -
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
|
Phase 2 | |
Enrolling by invitation |
NCT06055712 -
Antibiotic Prophylaxis in Pediatric Open Fractures
|
Phase 4 | |
Not yet recruiting |
NCT06338345 -
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
|
N/A | |
Not yet recruiting |
NCT06402292 -
Surgical Treatment of Osteoarticular Infections Using Bioactive Bone Substitute
|
N/A | |
Recruiting |
NCT06002685 -
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
|
N/A | |
Completed |
NCT02802059 -
E. Coli Nissle 1917 - Suspension for Infection Prophylaxis
|
Phase 3 | |
Completed |
NCT05289674 -
The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection
|
N/A | |
Recruiting |
NCT05770765 -
Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases
|
||
Completed |
NCT05389540 -
Rural South and Southeast Asia Household Health Survey
|